Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity

Nat Biotechnol. 1997 Feb;15(2):155-8. doi: 10.1038/nbt0297-155.

Abstract

Single chain fragment (ScFv) antiidiotypic antibodies (antilds) of a killer toxin (KT) from the yeast Pichia anomala have been produced by recombinant DNA methodology from the splenic lymphocytes of mice immunized by idiotypic vaccination with a KT-neutralizing monoclonal antibody (Mab KT4). ScFv KT-like antilds (KTIdAb) react with specific Candida albicans KT cell wall receptors (KTR) exerting a candidacidal activity in vitro could be neutralized by adsorption with Mab KT4. ScFv KTIdAb displayed an effective therapeutic activity in an experimental model of rat candidal vaginitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Anti-Idiotypic*
  • Antibodies, Monoclonal*
  • Candida albicans / drug effects
  • Candida albicans / immunology
  • Candida albicans / physiology
  • Candidiasis, Vulvovaginal / drug therapy*
  • DNA, Recombinant
  • Drug Design
  • Female
  • Genetic Engineering
  • Immunotoxins / pharmacology
  • Immunotoxins / therapeutic use*
  • Killer Factors, Yeast
  • Mice
  • Microbial Sensitivity Tests
  • Mycotoxins / biosynthesis
  • Mycotoxins / pharmacology
  • Mycotoxins / therapeutic use*
  • Pichia
  • Rats

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • DNA, Recombinant
  • Immunotoxins
  • Killer Factors, Yeast
  • Mycotoxins